During the past decade, UT Southwestern/Simmons Cancer Center-Fort Worth conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 8 clinical trials were completed, i.e. on average, 14.5% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 8 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UT Southwestern/Simmons Cancer Center-Fort Worth" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UT Southwestern/Simmons Cancer Center-Fort Worth" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Biologics, Inc." with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "UT Southwestern/Simmons Cancer Center-Fort Worth" are "Stage IIIB Lung Cancer AJCC v8" (5 trials), "Stage IV Lung Cancer AJCC v8" (4 trials), "Stage IV Renal Cell Cancer AJCC v8" (4 trials), "Invasive Breast Carcinoma" (3 trials) and "Lung Non-Squamous Non-Small Cell Carcinoma" (3 trials). Many other conditions were trialed in "UT Southwestern/Simmons Cancer Center-Fort Worth" in a lesser frequency.

Most popular intervention types in "UT Southwestern/Simmons Cancer Center-Fort Worth" are "Drug" (48 trials), "Biological" (29 trials), "Other" (28 trials), "Procedure" (24 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (15 trials), "Computed Tomography" (14 trials), "Biospecimen Collection" (13 trials), "Quality-of-Life Assessment" (13 trials) and "Cisplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "UT Southwestern/Simmons Cancer Center-Fort Worth" are 51 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "UT Southwestern/Simmons Cancer Center-Fort Worth". undefined are not yet recruiting, 26 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in UT Southwestern/Simmons Cancer Center-Fort Worth, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UT Southwestern/Simmons Cancer Center-Fort Worth, 1 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".